The REACT Study: Cost-Effectiveness Analysis of Assertive Community Treatment in North London

被引:0
|
作者
McCrone, Paul [1 ]
Killaspy, Helen [1 ]
Bebbington, Paul [1 ]
Johnson, Sonia [1 ]
Nolan, Fiona [1 ]
Pilling, Stephen [1 ]
King, Michael [1 ]
机构
[1] Kings Coll London, Hlth Serv & Populat Res Dept, Inst Psychiat PO24, London SE5 8AF, England
关键词
HOMELESS MENTALLY-ILL; SELF-REPORT; HEALTH; ILLNESS; SCALE; SCHIZOPHRENIA; INDIVIDUALS;
D O I
10.1176/ps.2009.60.7.908
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Assertive community treatment (ACT) is a key component of mental health care, but recent information on its cost-effectiveness is limited. This article provides a cost-effectiveness analysis of assertive community treatment and usual care from community mental health teams (CMHTs) in the United Kingdom. Methods: Participants who had difficulties engaging with community services were randomly assigned to ACT (N=127) or continued usual care from CMHTs (N=124). Costs were measured at baseline and 18 months later and compared between the two groups. In the analysis, cost data were linked to information on satisfaction, which had been shown to be significantly higher with ACT. Results: Total follow-up costs over 18 months were higher for the ACT group by L4,031 ($6,369), but this was not statistically significant (95% confidence interval of -L2,592 to L10,690 [-$4,095 to $16,890]). A one-unit improvement in satisfaction was associated with extra costs in the ACT group of L473 ($747). Conclusions: The costs of ACT were not significantly different from usual care. ACT did, however, result in greater levels of client satisfaction and engagement with services and as such may be the preferred community treatment option for patients with long-term serious mental health problems. (Psychiatric Services 60:908-913, 2009)
引用
收藏
页码:908 / 913
页数:6
相关论文
共 50 条
  • [31] COST-EFFECTIVENESS ANALYSIS OF IVABRADINE IN TREATMENT OF PATIENTS WITH HEART FAILURE IN IRAN
    Taheri, Saeed
    Heidari, Elham
    Aivazi, Mohammad Ali
    Shams-Beyranvand, Mehran
    Varmaghani, Mehdi
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2018, 34 (06) : 576 - 583
  • [32] Generalized Cost-Effectiveness Analysis to Assess Treatment Value in Hepatitis C
    Chou, Jacquelyn W.
    Graf, Marlon
    Espinosa, Oliver Diaz
    Brewer, Iris
    Heim, Zachary
    Baumgardner, James
    AMERICAN JOURNAL OF MANAGED CARE, 2023, 29 (12) : 696 - 703
  • [33] Cost-Effectiveness Analysis of Evolocumab for the Treatment of Dyslipidemia in the Kingdom of Saudi Arabia
    Alghamdi, Ahmed
    Balkhi, Bander
    Altowaijri, Abdulaziz
    Al-shehri, Nasser
    Ralph, Lewis
    Marriott, Emily-Ruth
    Urbich, Michael
    Aljanad, Fawaz
    Aziziyeh, Rima
    PHARMACOECONOMICS-OPEN, 2022, 6 (02) : 277 - 291
  • [34] Cost-effectiveness of olanzapine vs. aripiprazole in the treatment of schizophrenia
    Ascher-Svanum, Haya
    Stensland, Michael D.
    Peng, Xiaomei
    Faries, Douglas E.
    Stauffer, Virginia L.
    Osuntokun, Olawale O.
    Kane, John M.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (01) : 115 - 122
  • [35] Cost-effectiveness of measles treatment: a systematic review
    Nam Xuan Vo
    Anh Thi Van Nguyen
    Ha Thi Mai Tran
    Linh Thi Thuy Truong
    Nghi Ngoc Bao Nguyen
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2019, 69 (06) : S148 - S154
  • [36] Effectiveness of Forensic Assertive Community Treatment on Forensic and Health Outcomes: A Systematic Review and Meta-Analysis
    Goulet, Marie-Helene
    Dellazizzo, Laura
    Lessard-Deschenes, Clara
    Lesage, Alain
    Crocker, Anne G.
    Dumais, Alexandre
    CRIMINAL JUSTICE AND BEHAVIOR, 2022, 49 (06) : 838 - 852
  • [37] A cost-effectiveness study of the community-based intervention '10 000 Steps Ghent'
    De Smedt, Delphine
    De Cocker, Katrien
    Annemans, Lieven
    De Bourdeaudhuij, Ilse
    Cardon, Greet
    PUBLIC HEALTH NUTRITION, 2012, 15 (03) : 442 - 451
  • [38] Cost-Effectiveness of Positive Memory Training (PoMeT) for the Treatment of Depression in Schizophrenia
    Simon, Judit
    Kiss, Noemi
    Korrelboom, Kees
    Kingdon, David
    Wykes, Til
    Phiri, Peter
    van der Gaag, Mark
    Baksh, M. Fazil
    Steel, Craig
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (19)
  • [39] Cost-effectiveness analysis of intravitreal aflibercept in the treatment of diabetic macular edema in China
    Ming, Jian
    Zhang, Yabing
    Xu, Xun
    Zhao, Mingwei
    Wang, Yusheng
    Chen, Youxin
    Zhang, Feng
    Wang, Jiawei
    Liu, Jun
    Zhao, Xinran
    Han, Rong
    Hu, Shanlian
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2020, 9 (03) : 161 - 175
  • [40] Cost-Effectiveness of Faricimab in the Treatment of Diabetic Macular Oedema (DMO): A UK Analysis
    Buhrer, Christian
    Paling, Thomas
    Gale, Richard
    Paulo, Tatiana
    Bagijn, Marloes
    PHARMACOECONOMICS-OPEN, 2024, 8 (03) : 445 - 457